GlassScriptPhysician profile
Stewart G Eidelson
NPI 1790727253
$281,960.14
in general payments reported to CMS, 2019-2025
13 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110K · 2020: $69K · 2021: $39K · 2022: $23K · 2023: $29K · 2024: $12K · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $41K · Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $41,250.00 |
| Food and Beverage | $569.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Captiva Spine INC | $106,423.47 | 2019-2024 | Transfasten, Towerlox Ext |
| Stryker Corporation | $40,469.26 | 2019-2020 | |
| Life Spine, INC. | $36,624.72 | 2019-2021 | |
| Spinevision Sas | $33,386.91 | 2019-2020 | |
| Alphatec Spine, INC | $32,993.87 | 2020-2024 | Other - Miscellaneous, Invictus Mis, Biologics |
| Spineart USA INC | $15,594.18 | 2019-2021 | |
| Medacta USA, INC. | $11,183.12 | 2019 | |
| Cerapedics INC. | $3,054.85 | 2021 | |
| Medicrea USA, Corp. | $2,000.00 | 2019 | |
| Providence Medical Technology, INC. | $112.60 | 2025 | |
| Augmedics INC. | $59.33 | 2020 | |
| Abbott Laboratories | $41.62 | 2024 | Eterna |
| Depuy Synthes Sales INC. | $16.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stewart Eidelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.